PMID: 9553616Apr 29, 1998Paper

Therapeutic management of hematological malignancies in elderly patients. Biological and clinical considerations. Part III: The chronic leukemias and myelofibrosis

Aging : Clinical and Experimental Research
D QuaglinoA Campitelli

Abstract

The different therapeutic options available for the treatment of chronic leukemias and myelofibrosis are discussed. In reference to chronic myeloid leukemia (CML), the choice of the most appropriate treatment must take into account not only the clinical condition but also the age of the patient. While subjects under 50 might benefit from the options offered by alpha-interferon, bone marrow and peripheral stem cell transplant, in older age groups treatment of the chronic phase must still rely on standard treatment. Chronic lymphocytic leukemia (CLL) and its variants is a disease of mostly middle and late life, with a variable clinical course. Patients show wide differences in morbidity and mortality. Many features have been shown to influence the prognosis, and the most important ones are incorporated into the staging systems currently in use. The results obtained from the study of large trials support the concept that treatment of patients with stable stage A CLL should be postponed until progression of disease. Treatment relies principally on alkylating agents, corticosteroids and radiation therapy; the new nucleoside analogues, such as fludarabine and 2-chlorodeoxyadenosine, have recently acquired established value in improvi...Continue Reading

References

Mar 1, 1978·British Journal of Haematology·J W Adamson, P J Fialkow
Apr 1, 1992·British Journal of Haematology·A F List, D C Doll
Aug 1, 1991·British Journal of Haematology·D McCarthyF Giles
Jan 1, 1990·European Journal of Haematology·E LöfvenbergA Ost
Sep 1, 1986·British Journal of Haematology·M TalpazJ Gutterman
Nov 1, 1986·British Journal of Haematology·M PetriniB Grassi
Jan 1, 1985·British Journal of Haematology·D M McCarthy
Mar 21, 1966·JAMA : the Journal of the American Medical Association·B J Kennedy, J W Yarbro
Mar 1, 1969·Postgraduate Medicine·D S Rosenthal, W C Moloney
Jan 1, 1969·British Journal of Haematology·B E RobertsC G Woods
Dec 1, 1984·British Journal of Haematology·S Pittman, D Catovsky
Jun 1, 1980·Annals of Internal Medicine·J E Groopman
Mar 1, 1993·British Journal of Haematology·G BarosiR Guarnone
Jun 1, 1962·The American Journal of the Medical Sciences·B A BOURONCLE, C A DOAN

❮ Previous
Next ❯

Citations

Jun 11, 2009·European Journal of Haematology·Elisabeth AndrieEleni Th Petridou
Jun 26, 2013·Environmental and Molecular Mutagenesis·Bryan A BassigQing Lan

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.